Latest medical research, FDA approvals, and clinical trial updates
Lopinavir-ritonavir is not associated with improved outcomes in patients hospitalized with COVID-19, a new trial shows. Dr. Peter W. Horby from the RECOVERY Central Coordinating Office, Oxford, UK and colleagues…
The adjuvanted recombinant zoster vaccine Shingrix appears to be effective in older adults with autoimmune diseases who are not receiving treatment regimens that suppress the immune system, according to a…
The US Food and Drug Administration (FDA) wants updated boxed warnings on benzodiazepines to reflect the "serious" risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions associated with these medications.…
"More is not necessarily better" when it comes to vitamin D supplements for women with adequate serum levels, new research suggests. In a study of healthy 55- to 70-year-old women who took…
The largest study of its kind has found no positive association between personal use of permanent hair dye and the risk for most cancers and cancer mortality. The findings come…
Remdesivir has been safely used to treat an infant with severe COVID-19-related acute respiratory distress syndrome (ARDS), according to a case report. Remdesivir has shown promise for treating adults infected…
